Imperial College London

ProfessorJustinStebbing

Faculty of MedicineDepartment of Surgery & Cancer

Visiting Professor
 
 
 
//

Contact

 

j.stebbing Website CV

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Magbanua:2020:10.1158/1557-3265.LiqBiop20-A50,
author = {Magbanua, MJM and Li, W and Wolf, DM and Yau, C and Hirst, GL and Brown-Swigart, L and Chien, AJ and Delson, AL and Gibbs, J and Aleshin, A and Zimmerman, B and Esserman, L and Hylton, N and van't, Veer L},
doi = {10.1158/1557-3265.LiqBiop20-A50},
pages = {59--60},
publisher = {AMER ASSOC CANCER RESEARCH},
title = {Circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for monitoring and predicting response to neoadjuvant therapy (NAT) in high-risk early breast cancer patients in the I-SPY 2 TRIAL},
url = {http://dx.doi.org/10.1158/1557-3265.LiqBiop20-A50},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Magbanua,MJM
AU - Li,W
AU - Wolf,DM
AU - Yau,C
AU - Hirst,GL
AU - Brown-Swigart,L
AU - Chien,AJ
AU - Delson,AL
AU - Gibbs,J
AU - Aleshin,A
AU - Zimmerman,B
AU - Esserman,L
AU - Hylton,N
AU - van't,Veer L
DO - 10.1158/1557-3265.LiqBiop20-A50
EP - 60
PB - AMER ASSOC CANCER RESEARCH
PY - 2020///
SN - 1078-0432
SP - 59
TI - Circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for monitoring and predicting response to neoadjuvant therapy (NAT) in high-risk early breast cancer patients in the I-SPY 2 TRIAL
UR - http://dx.doi.org/10.1158/1557-3265.LiqBiop20-A50
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000537848000079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -